These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 13717218)

  • 1. [Determination of the properdin level with the aid of inulin and dry guinea pig complement].
    IAKOVLEV AM; KOMLEVA GG; IAKOVLEVA SD
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Nov; 31():58-63. PubMed ID: 13717218
    [No Abstract]   [Full Text] [Related]  

  • 2. Preservation of guinea-pig serum complement for its use in properdin assay using inulin.
    MAJUMDAR AC; SEN R; MUKERJI B
    Ann Biochem Exp Med; 1962 Aug; 22():209-12. PubMed ID: 14468640
    [No Abstract]   [Full Text] [Related]  

  • 3. Research on the properdin system. I. Inactivation of the third complement component through zymosan on inulin.
    HEISE ER
    Klin Wochenschr; 1958 Jan; 36(2):88-9. PubMed ID: 13540126
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relation between properdinemia and alexinemia in the guinea pig].
    DIACONO H; CASTAY M
    C R Seances Soc Biol Fil; 1960; 154():334-5. PubMed ID: 13816508
    [No Abstract]   [Full Text] [Related]  

  • 5. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V; Nicholson A; Lee GD; Mayer MM
    J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunochemical studies on the mechanism of allergic diseases. II. The complement and properdin titer of sensitized and anaphylactic shock-exposed guinea pigs].
    DRESSLER O
    Z Immun exp ther; 1959 Sep; 118():175-80. PubMed ID: 13818067
    [No Abstract]   [Full Text] [Related]  

  • 7. An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin.
    Marcus RL; Shin HS; Mayer MM
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1351-4. PubMed ID: 5288385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of Guinea pig properidin.
    Nicholson A; Austen KF
    J Immunol; 1977 Jan; 118(1):103-8. PubMed ID: 830742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The properdin system: composition and function.
    Brade V
    Vox Sang; 1978; 35(1-2):1-9. PubMed ID: 351959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
    Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
    J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine rich beta-glycoprotein (GBG or factor B).
    Brade V; Cook CT; Shin HS; Mayer MM
    J Immunol; 1972 Dec; 109(6):1174-81. PubMed ID: 4628703
    [No Abstract]   [Full Text] [Related]  

  • 13. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.
    Vogt W; Schmidt G; Lynen R; Dieminger L
    J Immunol; 1975 Feb; 114(2 Pt 1):671-7. PubMed ID: 804510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE; Spitzer RE
    J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
    [No Abstract]   [Full Text] [Related]  

  • 15. [ Complement activation by the alternate pathway (or properdin pathway) in paroxysmal nocturnal hemoglobinuria].
    Audran R
    Rev Fr Transfus; 1974 Dec; 17(4):333-48. PubMed ID: 4464553
    [No Abstract]   [Full Text] [Related]  

  • 16. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition by cinnarizine of the properdin-dependent activation of complement.
    Di Perri T; Auteri A; Pasini FL; Mattioli F
    Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):281-5. PubMed ID: 879911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of the cDNA encoding guinea-pig properdin: a comparison of properdin from three species.
    Maves KK; Guenthner ST; Densen P; Moser DR; Weiler JM
    Immunology; 1995 Nov; 86(3):475-9. PubMed ID: 8550088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DETERMINATION OF THE PROPERDIN LEVEL USING THE INULIN METHOD].
    PIETRUSKA Z
    Pol Arch Med Wewn; 1964; 34():1625-8. PubMed ID: 14323268
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.